CEMI
Chembio diagnostics, Inc.
CEMI
CEMI
Delisted
CEMI was delisted on the 27th of April, 2023.
36 hedge funds and large institutions have $2.33M invested in Chembio diagnostics, Inc. in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 17 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
-7
Holders Change %
-16.28%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
17
Closed
11
Calls
$53K
Puts
$116K
Net Calls
-$63K
Net Calls Change
+$129K
Top Buyers
| 1 |
Bank of New York Mellon
New York
|
+$102K |
| 2 |
RPCA
Running Point Capital Advisors
El Segundo,
California
|
+$8K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6K |
| 4 |
Jane Street
New York
|
+$4.83K |
| 5 |
BlackRock
New York
|
+$3.81K |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$247K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$157K |
| 3 |
RA
Royce & Associates
New York
|
-$146K |
| 4 |
Goldman Sachs
New York
|
-$105K |
| 5 |
PM
Penbrook Management
New York
|
-$91.8K |
